Molecular Cloning Market To Attain USD 8.89 Billion By 2034, Driven By Expanding Healthcare Applications And Innovation

2025-11-12 10:02:38

(MENAFN- GlobeNewsWire - Nasdaq) The global molecular cloning market size is calculated at USD 5.53 billion in 2025 and is expected to reach around USD 8.89 billion by 2034, growing at a CAGR of 5.4% for the forecasted period.

Ottawa, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The global molecular cloning market size

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @

Key Takeaways

North America held a major revenue share of the market in 2024.
Asia Pacific is expected to witness the fastest growth in the molecular cloning market during the forecast period.
By technique, the polymerase chain reaction segment held a major revenue share of the market in 2024.
By technique, the recombinant DNA technology segment is expected to witness significant growth in the market during the forecast period.
By application, the therapeutics segment held a major revenue share of the market in 2024.
By application, the genetic engineering segment is expected to witness significant growth in the market during the forecast period.
By product, the enzymes segment held a major revenue share of the market in 2024.
By product, the cloning kits segment is expected to witness significant growth in the market during the forecast period.
By end user, the academic research institutions segment held a major revenue share of the global molecular cloning market in 2024.
By end user, the contract research organizations segment is expected to witness significant growth in the market during the forecast period.

What is Molecular Cloning?

The molecular cloning market is driven by growing demand for personalized medicine gene therapy

You can place an order or ask any questions, please feel free to contact us at ...

What are the Major Growth Drivers in the Molecular Cloning Market?

The growing diseases are the major drivers in the market. This is increasing the demand for vaccinations

What are the Key Drifts in the Molecular Cloning Market?

The market has been expanding due to the growing collaborations to launch and enhance the use of various molecular cloning techniques.

In April 2025, a collaboration between Molecular Genetics Core and Oxford Nanopore Technologies was announced for enhancing the availability of PromethION 24 of Oxford Nanopore. Thus, to tackle complex genomics challenges, advanced, real-time, long-read sequencing services
In April 2025, to accelerate clinical adoption of next-generation sequencing tests, a collaboration between Illumina Inc. and Tempus AI, Inc. was announced. The AI technologies of Illumina and the multimodal data platform of Tempus will be combined to enhance genomic algorithms and clinical adoption of molecular testing for patients.

What is the Significant Challenge in the Molecular Cloning Market?

High cost acts as the major challenge in the market. Molecular cloning requires advanced equipment and reagents, which are often expensive, limiting the adoption by startups and smaller labs. Moreover, technical complexities, contamination risk, limited infrastructure, and regulatory challenges are the other market limitations.

Become a valued research partner with us -

Regional Analysis

Why did North America Dominate the Molecular Cloning Market in 2024?

In 2024, North America captured the biggest revenue share in the market, due to the presence of advanced industries, which contributed to the increased use of molecular cloning for genetic research and drug discoveries

What Made the Asia Pacific Show the Fastest Growth in the Molecular Cloning Market in 2024?

Asia Pacific is expected to host the fastest-growing cannabidiol market during the forecast period, due to expanding industries, which are increasing the production of vaccines, biosimilars, and biopharmaceuticals

Segmental Insights

By technique analysis

Why Did the Polymerase Chain Reaction Segment Dominate in the Molecular Cloning Market in 2024?

By technique, the polymerase chain reaction segment held the largest share of the market in 2024, due to its high sensitivity. At the same time, they can develop millions of DNA copies in a few hours, which enhances their adaptation rates. Additionally, their specificity increases their use in various applications.

By technique, the recombinant DNA technology segment is expected to grow significantly in the market during the predicted time, driven by growth in R&D activities. This, in turn, is increasing their use in the development of vaccines, antibodies, gene therapies, as well as genetically modified organisms. Moreover, government funding is enhancing their adoption rates.

By application analysis

Get the latest insights on life science industry segmentation with our Annual Membership:

What Made Therapeutics the Dominant Segment in the Molecular Cloning Market in 2024?

By application, the therapeutics segment led the market in 2024, due to its increased use in the development of vaccines and recombinant proteins

By application, the genetic engineering segment is expected to show lucrative growth in the market during the predicted time, due to growing innovations. Different types of genetic tools, along with the integration of AI, are increasing their use for R&D. Thus, their growing applications and expanding industries are increasing their use.

By product analysis

Which Product Type Segment Held the Dominating Share of the Molecular Cloning Market in 2024?

By product, the enzymes segment held the dominating share of the market in 2024, as they were essential for various core processes. This, in turn, increased their continuous use across various areas. At the same time, the growth in R&D, technological innovations, and their easy scalability increased their adoption rates across the industries.

By product, the cloning kits segment is expected to grow significantly in the market during the upcoming years, driven by their easy use and time-saving approach. They also provide high efficiency and consistent outcomes. This, in turn, is driving their demand in industries, institutes, and labs.

By end-user analysis

How did the Academic Research Institutions Segment Dominated the Molecular Cloning Market in 2024?

By end user, the academic research institutions segment led the global molecular cloning market in 2024, due to their high volume of experiments. Moreover, the growth in the R&D and training programs also increased their use. Additionally, the growth in government funding and investments also enhanced their adoption rates.

By end user, the contract research organizations segment is expected to show lucrative growth in the market during the upcoming years, due to their specialized services and expertise. They provided advanced molecular cloning capabilities and reduced the operational expenses. Furthermore, the growing outsourcing trend is also leading to new collaborations.

Browse More Insights of Towards Healthcare:

The global molecular spectroscopy market

The molecular cytogenetics market

The molecular diagnostics market

The molecular interaction analyzer market

The U.S. oncology molecular diagnostics market

The core clinical molecular diagnostics market

The global oncology molecular diagnostics market

The global point-of-care molecular diagnostics market

Recent Developments in the Molecular Cloning Market

In February 2025, expanded global access to high-quality, low-cost DNA sequencing was announced by Ultima Genomics, Inc., where these DNA sequencing services will provide applications like single-cell sequencing, whole genome sequencing, proteomics, spatial transcriptomics, etc, with the use of UG 100.
In February 2025, a new category of next-generation sequencing was revealed by Roche with the launch of its proprietary, breakthrough sequencing by expansion (SBX) technology.
In February 2025, the largest portfolio of omics solutions, such as genomics, single-cell analysis, spatial transcriptomics, etc, and sequencing applications was unveiled by Illumina, Inc.

Molecular Cloning Market Key Players List

Clontech Laboratories
Thermo Fisher Scientific
Qiagen
Sigma-Aldrich
Biotechnology Company
Agilent Technologies
Addgene
New England Biolabs
Illumina
Sangamo Therapeutics
Takara Bio
Merck KGaA
Genscript
Promega Corporation

Segments Covered in The Report

By Technique

Restriction Fragment Length Polymorphism
Polymerase Chain Reaction
Recombinant DNA Technology
DNA Sequencing
Gel Electrophoresis

By Application

Therapeutics
Genetic Engineering
Agricultural Biotechnology
Synthetic Biology

By Product

Enzymes
Vector Systems
Cloning Kits
Competent Cells

By End User

Academic Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations

By Region

North America

U.S.
Canada
Mexico
Rest of North America

South America

Brazil
Argentina
Rest of South America

Europe

Western Europe

Germany
Italy
France
Netherlands
Spain
Portugal
Belgium
Ireland
UK
Iceland
Switzerland
Poland
Rest of Western Europe

Eastern Europe

Austria
Russia & Belarus
Türkiye
Albania
Rest of Eastern Europe

Asia Pacific

China
Taiwan
India
Japan
Australia and New Zealand,
ASEAN Countries (Singapore, Malaysia)
South Korea
Rest of APAC

MEA

GCC Countries
Saudi Arabia
United Arab Emirates (UAE)
Qatar
Kuwait
Oman
Bahrain
South Africa
Egypt
Rest of MEA

Immediate Delivery Available | Buy This Premium Research @

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard:

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research

You can place an order or ask any questions, please feel free to contact us at ...

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web:

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

MENAFN12112025004107003653ID1110333481

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.